Curtis Rambaran

624 total citations · 3 hit papers
19 papers, 462 citations indexed

About

Curtis Rambaran is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Curtis Rambaran has authored 19 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 5 papers in Surgery and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Curtis Rambaran's work include Cardiovascular Health and Disease Prevention (7 papers), Lipoproteins and Cardiovascular Health (4 papers) and Blood Pressure and Hypertension Studies (4 papers). Curtis Rambaran is often cited by papers focused on Cardiovascular Health and Disease Prevention (7 papers), Lipoproteins and Cardiovascular Health (4 papers) and Blood Pressure and Hypertension Studies (4 papers). Curtis Rambaran collaborates with scholars based in United Kingdom, United States and Jamaica. Curtis Rambaran's co-authors include Steven E. Nissen, Michael J. Koren, Leslie Cho, Gerald F. Watts, Kausik K. Ray, Kathy Wolski, Lalit Kalra, Traci Turner, Ajay M. Shah and Rosamund Wilson and has published in prestigious journals such as JAMA, Circulation and Blood.

In The Last Decade

Curtis Rambaran

19 papers receiving 454 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels

2022 209 citations Steven E. Nissen, Kathy Wolski et al. JAMA profile →
Zerlasiran—A Small-Interfering RNA Targeting Lipoprotein(a)

2024 49 citations Steven E. Nissen, Qiuqing Wang et al. JAMA profile →
Single Ascending and Multiple-Dose Trial of Zerlasiran, a Short Interfering RNA Targeting Lipoprotein(a)

2024 43 citations Steven E. Nissen, Kathy Wolski et al. JAMA profile →

Peers

Curtis Rambaran

SURGE

CCM

EDM

Adam Sukiennik Poland

Koji Yanagi Japan

Qinhua Chen China

Ji Won Son South Korea

Elsa Valdés‐Márquez United Kingdom

Federico Bigazzi Italy

John V. Mitsios Greece

Adam Taleb United States

Rutger Verbeek Netherlands

Adam Sukiennik Poland

Curtis Rambaran

315 ×1.2

SURGE

327 ×1.8

CCM

149 ×1.5

EDM

59 ×0.9

59 ×1.0

Citations per year, relative to Curtis Rambaran Curtis Rambaran (= 1×) peers Adam Sukiennik

Countries citing papers authored by Curtis Rambaran

Since Specialization

Citations

This map shows the geographic impact of Curtis Rambaran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Curtis Rambaran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Curtis Rambaran more than expected).

Fields of papers citing papers by Curtis Rambaran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Curtis Rambaran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Curtis Rambaran. The network helps show where Curtis Rambaran may publish in the future.

Co-authorship network of co-authors of Curtis Rambaran

This figure shows the co-authorship network connecting the top 25 collaborators of Curtis Rambaran. A scholar is included among the top collaborators of Curtis Rambaran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Curtis Rambaran. Curtis Rambaran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Nissen, Steven E., Kathy Wolski, Gerald F. Watts, et al.. (2024). Single Ascending and Multiple-Dose Trial of Zerlasiran, a Short Interfering RNA Targeting Lipoprotein(a). JAMA. 331(18). 1534–1534. 43 indexed citations breakdown →

Kremyanskaya, Marina, Lee Ping Chew, Hanlon Sia, et al.. (2024). Initial Results from a Phase 1/2 Study Evaluating Divesiran, a Novel Galnac Conjugated siRNA, in Patients with Polycythemia Vera (SANRECO). Blood. 144(Supplement 1). 656–656. 1 indexed citations

Nissen, Steven E., Qiuqing Wang, Stephen J. Nicholls, et al.. (2024). Zerlasiran—A Small-Interfering RNA Targeting Lipoprotein(a). JAMA. 332(23). 1992–1992. 49 indexed citations breakdown →

Rambaran, Curtis, et al.. (2022). Abstract 10469: Time Averaged Lipoprotein(a) Reduction With Sln360, a Novel Sirna Targeting Lp(a,) in Healthy Adults With Elevated Lp(a). Circulation. 146(Suppl_1). 2 indexed citations

Nissen, Steven E., Kathy Wolski, Craig Balog, et al.. (2022). Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels. JAMA. 327(17). 1679–1679. 209 indexed citations breakdown →

Januzzi, James L., John M. Canty, Saumya Das, et al.. (2021). Gaining Efficiency in Clinical Trials With Cardiac Biomarkers. Journal of the American College of Cardiology. 77(15). 1922–1933. 8 indexed citations

Marbury, Thomas, et al.. (2020). NaPi-IIb Inhibition for Hyperphosphatemia in CKD Hemodialysis Patients. Kidney International Reports. 6(3). 675–684. 13 indexed citations

Limsakun, Tharin, Victor Dishy, Jeanne Mendell, et al.. (2020). Safety and Pharmacokinetics of DS‐1040 Drug‐Drug Interactions With Aspirin, Clopidogrel, and Enoxaparin. The Journal of Clinical Pharmacology. 60(6). 691–701. 3 indexed citations

Cahn, Anthony, Malcolm Boyce, S. Mistry, et al.. (2015). Randomized trial of allergen‐induced asthmatic response in smokers and non‐smokers: effects of inhaled corticosteroids. Clinical & Experimental Allergy. 45(10). 1531–1541. 8 indexed citations

10.

Gale, Nichola, Ali Albarrati, M. Munnery, et al.. (2014). Assessment of Risk in Chronic Airways Disease Evaluation (ARCADE). Chronic Respiratory Disease. 11(4). 199–207. 6 indexed citations

11.

Wilson, Robert C., et al.. (2013). Safety, tolerability and pharmacokinetics (PK) of single and repeat nebulised doses of a novel phosphoinositide 3-kinase δ inhibitor (PI3Kδ), GSK2269557, administered to healthy male subjects in a phase I study. European Respiratory Journal. 42(Suppl 57). P729–P729. 6 indexed citations

12.

Gale, Nichola, M. Munnery, Ali Albarrati, et al.. (2012). Abstracts. Journal of Clinical Hypertension. 14(s1). A1–A144. 1 indexed citations

13.

Kalra, Lalit, Elizabeth Iveson, Curtis Rambaran, et al.. (2007). An international matched cohort study of the contribution of metabolic impairments to subclinical atherosclerosis in United Kingdom and Jamaican African-Caribbeans. Atherosclerosis. 199(1). 95–101. 8 indexed citations

14.

Rambaran, Curtis, Benyu Jiang, James M. Ritter, et al.. (2007). Assessment of endothelial function: comparison of the pulse wave response to β₂‐adrenoceptor stimulation with flow mediated dilatation. British Journal of Clinical Pharmacology. 65(2). 238–243. 27 indexed citations

15.

Kalra, Lalit, Elizabeth Iveson, Curtis Rambaran, et al.. (2007). Homocysteine, migration and early vascular impairment in people of African descent. Heart. 94(9). 1171–1174. 2 indexed citations

16.

Rambaran, Curtis, Phil Chowienczyk, James M. Ritter, et al.. (2006). The vascular effects of metabolic impairment clusters in subjects of different ethnicities. Atherosclerosis. 192(2). 354–362. 6 indexed citations

17.

Kalra, Lalit, Curtis Rambaran, Elizabeth Iveson, et al.. (2006). The Role of Inheritance and Environment in Predisposition to Vascular Disease in People of African Descent. Journal of the American College of Cardiology. 47(6). 1126–1133. 15 indexed citations

18.

Adamson, Rosemary, Curtis Rambaran, & David D’Cruz. (2005). Anabolic steroid-induced rhabdomyolysis. British Journal of Hospital Medicine. 66(6). 362–362. 13 indexed citations

19.

Kalra, Lalit, Curtis Rambaran, Phil Chowienczyk, et al.. (2005). Ethnic Differences in Arterial Responses and Inflammatory Markers in Afro-Caribbean and Caucasian Subjects. Arteriosclerosis Thrombosis and Vascular Biology. 25(11). 2362–2367. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact